SMARTphone Based Cardiovascular Risk Reduction in BREAST Cancer Patients [SMART-BREAST]: A Randomized Controlled Trial

The aim of this study is to establish the efficacy of a smartphone-based cardiovascular risk reduction program in women undergoing treatment for breast cancer. This will be achieved by testing our personalized smartphone application "BreastMate", as an adjunct to standard care in a multi-centre randomized controlled trial. 

The efficacy of the smartphone app will be assessed in the following domains:

          1. Exercise capacitya. 6-minute walk test (6MWT)

          2. Cardiovascular risk factor parameters

                     a. Blood pressure (mmHg)

                     b. Lipid profile (total cholesterol, LDL-cholesterol, triglycerides)

                     c. Fasting glucose levels and HbA1C

                     d. Smoking status assessed by self-reporting

                     e. Weight and body mass index (BMI)

           3. Received dose intensity of chemotherapy (RDI)

           4. Incidence of Cancer therapy related severe adverse events 

           5. Incidence of Venous thromboembolism

           6. Quality of life

                       a. SF-36 questionnaire


Project Owner

Alex Murphy

Project Information

Institution

- Austin Health


Research Parts

- Literature Review

- Research proposal

- Ethics Approval

- Data Collection


Positions Available

- Multi-site data collection


End Date

05/03/2021


How To Apply

Please fill out the form below to express your interest in this research project. It is free to contact a project owner and express interest in a project. We recommend writing a detailed message regarding why you are interested in the project (e.g. what skills you can bring to the team) or what information you are seeking (e.g. detail regarding the study duration). All information you provide will be shared with the primary researcher, including your contact details. Thank you for your interest in this project.